Lynn Decoster

UNcommon EGFR Mutations: International Case Series on Efficacy of Osimertinib in Real-Life Practice in First-LiNe Setting (UNICORN)

Jair Bar, Nir Peled, Shiruyeh Schokrpur et al. · Journal of Thoracic Oncology · 2022 · 97 citations · Full text

Medicine, Oncology, Pharmacology +14

The genomic landscape of nonsmall cell lung carcinoma in never smokers

Bram Boeckx, Rajendra Bahadur Shahi, Dominiek Smeets et al. · International Journal of Cancer · 2019 · 43 citations · Full text

Life Sciences, Genetics, Oncology +17

HLA-I diversity and tumor mutational burden by comprehensive next-generation sequencing as predictive biomarkers for the treatment of non-small cell lung cancer with PD-(L)1 inhibitors

Kristof Cuppens, Ellen Geerdens, Bert Cruys et al. · Lung Cancer · 2022 · 24 citations · Full text

Medicine, Immunology, Oncology +17

A nationwide comprehensive genomic profiling and molecular tumor board platform for patients with advanced cancer

Pieter‐Jan Volders, Philippe Aftimos, Franceska Dedeurwaerdere et al. · npj Precision Oncology · 2025 · 20 citations · Full text

Medicine, Molecular Medicine, Oncology +17

Dramatic Response to First Line Single Agent Pembrolizumab in Anaplastic Thyroid Carcinoma

Valérie Spalart, Barbara Legius, Kurt Segers et al. · Case Reports in Endocrinology · 2019 · 18 citations · Full text

Pharmacy, Oncology, Pharmacotherapy +12